New Jersey Medical School (NJMS), Surgery

Medicine & Life Sciences

1. Wounds and Injuries 100%
2. Liver Transplantation 42%
3. Hemorrhagic Shock 34%
4. Palliative Care 31%
5. Sepsis 28%
6. Mortality 26%
7. Surgeons 23%
8. Trauma Centers 21%
9. Inflammation 20%
10. Bone Marrow 19%
11. Neutrophils 19%
12. Endotoxins 19%
13. Critical Care 18%
14. Intensive Care Units 18%
15. Liver 18%
16. Transplants 16%
17. Monocytes 14%
18. Pediatrics 13%
19. Therapeutics 13%
20. Laparotomy 12%
21. Traumatic Brain Injury 12%
22. Infections 12%
23. Animals 12%
24. Length of Stay 12%
25. Tissue Donors 12%
26. Endotoxemia 11%
27. Lung 11%
28. Multicenter Studies 11%
29. Cytokines 11%
30. Resuscitation 11%
31. Morbidity 11%
32. Craniocerebral Trauma 11%
33. Erythroid Precursor Cells 11%
34. Hemorrhage 11%
35. Violence 11%
36. Systematic Reviews 11%
37. Lymph 11%
38. Glucosephosphate Dehydrogenase 11%
39. Herniorrhaphy 10%
40. Transplant Recipients 10%
41. Emergencies 10%
42. Anti-Inflammatory Agents 10%
43. Shock 10%
44. Population 10%
45. Skin 10%
46. Hospital Emergency Service 9%
47. Erythrocytes 9%
48. Contusions 9%
49. Lipopolysaccharides 8%
50. Lung Injury 8%
51. Survival 8%
52. Thromboplastin 8%
53. Comorbidity 8%
54. Communication 8%
55. Quality Improvement 8%
56. Thorax 8%
57. Gunshot Wounds 8%
58. Interleukin-10 8%
59. Patient Care Planning 8%
60. Mosaicism 7%
61. Neoplasms 7%
62. Debridement 7%
63. Bone Marrow Cells 7%
64. Colectomy 7%
65. Interleukin-6 7%
66. Hematopoietic Stem Cells 7%
67. Gastrectomy 7%
68. Pandemics 7%
69. Hepatocellular Carcinoma 7%
70. Electroacupuncture 7%
71. Demography 7%
72. Firearms 7%
73. Laparoscopy 7%
74. Transplantation 7%
75. Burns 7%
76. Inpatients 7%
77. Motor Vehicles 7%
78. Endothelial Cells 7%
79. lithocholyl-N-hydroxysuccinimide 7%
80. Randomized Controlled Trials 7%
81. Nicotinic Receptors 6%
82. Wound Healing 6%
83. Cholangiocarcinoma 6%
84. Pedestrians 6%
85. Fatty Liver 6%
86. Mesenchymal Stem Cells 6%
87. Perfusion 6%
88. Coronavirus 6%
89. Ischemic Preconditioning 6%
90. Vagus Nerve Stimulation 6%
91. Databases 6%
92. Anti-Bacterial Agents 6%
93. Critical Illness 6%
94. Injury Severity Score 6%
95. ethyl pyruvate 6%
96. Interleukin-8 6%
97. Tomography 6%
98. Frailty 6%
99. Cholinergic Agents 6%
100. Oxidative Stress 6%
101. Granulocyte-Macrophage Progenitor Cells 6%
102. Abdominal Wall 6%
103. Safety 6%
104. Immune System 6%
105. Tumor Necrosis Factor-alpha 5%
106. Macrophages 5%
107. Elderly 5%
108. End Stage Liver Disease 5%
109. Odds Ratio 5%
110. Adult Respiratory Distress Syndrome 5%
111. alpha7 Nicotinic Acetylcholine Receptor 5%
112. Geriatrics 5%
113. Spleen 5%
114. Lower Extremity 5%
115. Ventral Hernia 5%
116. Vagus Nerve 5%
117. Blood Vessels 5%
118. Ligation 5%
119. Neuroimmunomodulation 5%
120. Respiratory Burst 5%
121. Costs and Cost Analysis 5%
122. Kupffer Cells 5%
123. Plastic Surgery 5%
124. Ventilator-Associated Pneumonia 5%
125. Calcium 5%
126. X Chromosome 5%
127. Referral and Consultation 5%
128. Inguinal Hernia 5%
129. Logistic Models 5%
130. Growth 5%
131. Practice Guidelines 5%
132. Physicians 5%
133. Nervous System 5%
134. Innate Immunity 5%
135. Kidney 5%
136. Joints 5%
137. Glucosephosphate Dehydrogenase Deficiency 5%